Francois Mouton-Liger
Overview
Explore the profile of Francois Mouton-Liger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
1036
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sindzingre L, Bouaziz-Amar E, Mouton-Liger F, Cognat E, Dumurgier J, Gotze K, et al.
J Neuroendocrinol
. 2025 Jan;
e13493.
PMID: 39842780
Alzheimer's disease (AD) is associated with early metabolic dysfunction and adiponectin, which may play a pathophysiological role. Adiponectin is implicated in the regulation of energy homeostasis, carbohydrate, and lipid metabolism,...
2.
Decaix T, Mouton-Liger F, Dumurgier J, Cognat E, Vrillon A, Hugon J, et al.
J Prev Alzheimers Dis
. 2025 Jan;
12(1):100009.
PMID: 39800467
Background: The use of cerebrospinal (CSF) biomarkers in the diagnosis of Alzheimer's disease (AD) has been gaining interest in clinical practice. Although their usefulness has been demonstrated, their potential value...
3.
Gouilly D, Vrillon A, Bertrand E, Goubeaud M, Catala H, Germain J, et al.
Neuroimage Clin
. 2024 Jun;
43:103626.
PMID: 38850834
Background: PET imaging of the translocator protein (TSPO) is used to assess in vivo brain inflammation. One of the main methodological issues with this method is the allelic dependence of...
4.
Sindzingre L, Bouaziz-Amar E, Mouton-Liger F, Cognat E, Dumurgier J, Vrillon A, et al.
J Nutr Health Aging
. 2024 Jan;
28(3):100166.
PMID: 38280832
Adiponectin is an adipokine playing a central role in the regulation of energy homeostasis, carbohydrate and lipid metabolism, as well as immunomodulation. The relationship between Alzheimer's disease (AD) and body...
5.
Lilamand M, Bouaziz-Amar E, Dumurgier J, Cognat E, Hourregue C, Mouton-Liger F, et al.
J Gerontol A Biol Sci Med Sci
. 2023 May;
78(7):1307-1308.
PMID: 37208788
No abstract available.
6.
Gotze K, Vrillon A, Bouaziz-Amar E, Mouton-Liger F, Hugon J, Martinet M, et al.
Neurobiol Dis
. 2022 Dec;
176:105937.
PMID: 36462720
Objective: To explore the accuracy of plasma neurofilament light chain (NfL) as a biomarker for diagnosis and staging of cognitive impairment, in a large cohort with of previously diagnosed patients...
7.
Lilamand M, Bouaziz-Amar E, Dumurgier J, Cognat E, Hourregue C, Mouton-Liger F, et al.
J Gerontol A Biol Sci Med Sci
. 2022 Nov;
78(4):645-652.
PMID: 36441007
Background: Metabolic dysfunction and dysregulation of leptin signaling have been linked to Alzheimer's disease (AD)'s pathophysiology. The objectives of this study were to examine the associations between plasma leptin, cerebrospinal...
8.
Lilamand M, Clery J, Vrillon A, Mouton-Liger F, Cognat E, Gaubert S, et al.
Int J Mol Sci
. 2022 Nov;
23(21).
PMID: 36362275
Background: Alpha-synuclein, abnormally aggregated in Dementia with Lewy Bodies (DLB), could represent a potential biomarker to improve the differentiation between DLB and Alzheimer’s disease (AD). Our main objective was to...
9.
Clergue-Duval V, Vrillon A, Jeanblanc J, Questel F, Azuar J, Fouquet G, et al.
Addict Biol
. 2022 Oct;
27(6):e13232.
PMID: 36301211
In this translational study, we investigated the plasma tau protein, neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP) and ubiquitin carboxy-terminal hydrolase L1 (UCHL1), which are established biomarkers of...
10.
Gaubert S, Hourregue C, Mouton-Liger F, Millot P, Franco M, Amar-Bouaziz E, et al.
Neurosci Biobehav Rev
. 2022 Sep;
141:104856.
PMID: 36084847
Importance: Dementia with Lewy bodies (DLB) is a neurodegenerative disease linked to abnormal accumulation of phosphorylated α-synuclein. GBA1 is the gene encoding the lysosomal enzyme glucocerebrosidase (GCase), whose mutations are...